Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 331

1.

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, Leroi I, Pozo-Rodriguez F, Minthon L, Londos E.

Lancet Neurol. 2009 Jul;8(7):613-8. doi: 10.1016/S1474-4422(09)70146-2. Epub 2009 Jun 10.

PMID:
19520613
2.

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.

Emre M, Tsolaki M, Bonuccelli U, Destée A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladström A, Jones R; 11018 Study Investigators.

Lancet Neurol. 2010 Oct;9(10):969-77. doi: 10.1016/S1474-4422(10)70194-0. Epub 2010 Aug 20.

PMID:
20729148
3.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
4.

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.

Wang HF, Yu JT, Tang SW, Jiang T, Tan CC, Meng XF, Wang C, Tan MS, Tan L.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):135-43. doi: 10.1136/jnnp-2014-307659. Epub 2014 May 14. Review.

PMID:
24828899
5.

Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies.

Wesnes KA, Aarsland D, Ballard C, Londos E.

Int J Geriatr Psychiatry. 2015 Jan;30(1):46-54. doi: 10.1002/gps.4109. Epub 2014 Apr 16.

PMID:
24737460
6.

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.

Larsson V, Engedal K, Aarsland D, Wattmo C, Minthon L, Londos E.

Dement Geriatr Cogn Disord. 2011;32(4):227-34. doi: 10.1159/000334523. Epub 2011 Nov 25.

PMID:
22122992
7.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
8.

Cholinesterase inhibitors for dementia with Lewy bodies.

Wild R, Pettit T, Burns A.

Cochrane Database Syst Rev. 2003;(3):CD003672. Review.

PMID:
12917981
9.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(1):CD003154. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD003154.

PMID:
12535459
10.

Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment.

Johansson C, Ballard C, Hansson O, Palmqvist S, Minthon L, Aarsland D, Londos E.

Int J Geriatr Psychiatry. 2011 Feb;26(2):206-13. doi: 10.1002/gps.2516.

PMID:
20665553
11.

A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.

Thomas AJ, Burn DJ, Rowan EN, Littlewood E, Newby J, Cousins D, Pakrasi S, Richardson J, Sanders J, McKeith IG.

Int J Geriatr Psychiatry. 2005 Oct;20(10):938-44.

PMID:
16163744
12.

Treatment of dementia with Lewy bodies and Parkinson's disease dementia.

Ballard C, Kahn Z, Corbett A.

Drugs Aging. 2011 Oct 1;28(10):769-77. doi: 10.2165/11594110-000000000-00000. Review.

PMID:
21970305
13.

Randomized controlled trial of memantine in dementia associated with Parkinson's disease.

Leroi I, Overshott R, Byrne EJ, Daniel E, Burns A.

Mov Disord. 2009 Jun 15;24(8):1217-21. doi: 10.1002/mds.22495.

PMID:
19370737
14.

Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies.

Camicioli R, Gauthier S.

Can J Neurol Sci. 2007 Mar;34 Suppl 1:S109-17. Review.

PMID:
17469693
15.

[Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].

Drach LM.

Med Monatsschr Pharm. 2011 Feb;34(2):47-52; quiz 53-4. Review. German.

PMID:
21428015
16.

The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia.

Larsson V, Aarsland D, Ballard C, Minthon L, Londos E.

Int J Geriatr Psychiatry. 2010 Oct;25(10):1030-8. doi: 10.1002/gps.2506.

PMID:
20872929
17.
18.

Memantine improves goal attainment and reduces caregiver burden in Parkinson's disease with dementia.

Leroi I, Atkinson R, Overshott R.

Int J Geriatr Psychiatry. 2014 Sep;29(9):899-905. doi: 10.1002/gps.4077. Epub 2014 Feb 7.

PMID:
24510471
19.

Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.

Aarsland D, Ballard C, Rongve A, Broadstock M, Svenningsson P.

Curr Neurol Neurosci Rep. 2012 Oct;12(5):492-501. doi: 10.1007/s11910-012-0290-7.

PMID:
22806065
20.

Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia.

Horimoto Y, Matsumoto M, Nakazawa H, Yuasa H, Morishita M, Akatsu H, Ikari H, Yamamoto T, Kosaka K.

J Neurol Sci. 2003 Dec 15;216(1):105-8.

PMID:
14607310

Supplemental Content

Support Center